Skip to main navigation Skip to search Skip to main content

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

Research output: Contribution to journalEditorialOtherpeer-review

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalHIV Medicine
Volume16
Issue numberS1
DOIs
Publication statusPublished - 1 Apr 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antiretroviral therapy
  • CD4-guided ART
  • HIV
  • START trial
  • When to start

Cite this